HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer

Enabled resistance or innate insensitiveness to antiandrogen are lethal for castration-resistant prostate cancer (CRPC). Unfortunately, there seems to be little can be done to overcome the antiandrogen resistance because of the largely unknown mechanisms. In prospective cohort study, we found that H...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Shimiao, Yang, Zhao, Zhang, Zheng, Zhang, Hongli, Li, Songyang, Wu, Tao, Chen, Xuanrong, Guo, Jianing, Wang, Aixiang, Tian, Hao, Yu, Jianpeng, Zhang, Changwen, Su, Lei, Shang, Zhiqun, Quan, Changyi, Niu, Yuanjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042887/
https://www.ncbi.nlm.nih.gov/pubmed/36973255
http://dx.doi.org/10.1038/s41419-023-05742-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042887/
https://www.ncbi.nlm.nih.gov/pubmed/36973255
http://dx.doi.org/10.1038/s41419-023-05742-y

Ejemplares similares